Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis Academic Article

authors

• Zhong, Lixian

published proceedings

• PLoS ONE

altmetric score

• 5.5

author list (cited authors)

• Zhong, L., Pon, V., Srinivas, S., Nguyen, N., Frear, M., Kwon, S., ... Wilson, L.

citation count

• 23

complete list of authors

• Zhong, Lixian||Pon, Vickie||Srinivas, Sandy||Nguyen, Nicole||Frear, Meghan||Kwon, Sherry||Gong, Cynthia||Malmstrom, Robert||Wilson, Leslie

editor list (cited editors)

• Kyprianou, N.

publisher

• Public Library of Science (PLoS)  Publisher

published in

• PLoS ONE  Journal

keywords

• Antineoplastic Agents
• Cost-benefit Analysis
• Docetaxel
• Humans
• Male
• Neoplasm Metastasis
• Orchiectomy
• Probability
• Prostatic Neoplasms
• Quality-adjusted Life Years
• Taxoids
• Treatment Outcome

PubMed Central ID

• 23717582

Digital Object Identifier (DOI)

• 10.1371/journal.pone.0064275

start page

• e64275

end page

• e64275

volume

• 8

issue

• 5

URL

• http://dx.doi.org/10.1371/journal.pone.0064275

user-defined tag

• 3 Good Health and Well-Being